FP
INFI

Financial Perspectives’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Financial Perspectives’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,000
Closed -$11.7K – 605
2020
Q3 		$11.7K Hold
10,000
– – 0.01% 355
2020
Q2 		$9.05K Hold
10,000
– – 0.01% 358
2020
Q1 		$8.38K Hold
10,000
– – 0.01% 339
2019
Q4 		$9.6K Buy
+10,000
New +$11K 0.01% 335

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Financial Perspectives's INFI Position: Q4 2020 in Review

Financial Perspectives sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2020, closing a stake of 10,000 shares — an estimated $11.7K sold.

Financial Perspectives first reported a position in INFI in Q4 2019 and held it in 4 quarters. The position peaked at $11.7K in Q3 2020. 55 funds tracked by Wall St. Rank hold INFI as of Q4 2020.

  • Financial Perspectives reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Financial Perspectives sold 10,000 Infinity Pharmaceuticals, Inc. shares in Q4 2020, an estimated $11.7K.
  • Financial Perspectives first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2019 and held it in 4 quarters.
  • Financial Perspectives's Infinity Pharmaceuticals, Inc. position peaked at $11.7K in Q3 2020.
  • 55 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2020.

Based on Financial Perspectives's 13F filing for Q4 2020, filed 10 Jan 2024.